Eisai and advocacy leaders this week launched a digital platform called Kompass to help patients and caregivers navigate kidney cancer. The platform combines trusted information from leading organizations on one website, offering guidance at every stage of a person’s kidney cancer journey. It also promotes more informed health decisions.
Addressing confusion around a kidney cancer diagnosis is the central aim of Kompass. This resource was developed through collaboration with groups such as KCCure, KidneyCAN, the Kidney Cancer Association, and the National Kidney Foundation. Many individuals first learn they have kidney cancer during unrelated medical imaging. A large proportion faces advanced disease at diagnosis. Finding reliable information quickly remains a challenge for families.
Kompass, accessible via www.KidneyCancerKompass.com, brings together nearly 50 curated, credible resources in an easy-to-navigate format. Users can find practical support, educational materials, and tools tailored to their needs. The platform helps them understand complex medical terminology and make decisions with confidence.
Patients often struggle to know where to begin when a sudden influx of medical information arrives. Therefore, Kompass asks visitors a few questions about their situation and journey stage. It then curates suitable resources for their specific needs.
“People facing kidney cancer often feel overwhelmed and isolated,” said Teresa Cronin, Vice President of Corporate Communications and Patient Advocacy at Eisai Inc. She explained that gathering trusted information in one location responds directly to feedback from patients and caregivers. These individuals often found resources difficult to locate when the diagnosis was new, and anxiety was high.
Moreover, the platform includes video guides, healthcare discussion tools, and survivor stories to support understanding of treatment options and lifestyle impacts of kidney cancer. In addition, visitors can access one-on-one support services, including patient navigation, helplines, counseling, and peer mentoring programs.
Aside from clinical resources, Kompass addresses daily living with kidney cancer. It provides advice on nutrition, self-care, insurance navigation, and financial support programs. The platform also links to online communities where patients and caregivers can connect with others facing similar challenges.
Kidney cancer, which most commonly presents as renal cell carcinoma, affects hundreds of thousands of people globally each year. Renal cell carcinoma accounts for about nine out of 10 cases. A significant number of diagnoses happen when the disease has already progressed. Early guidance is especially important for outcome planning and quality of life.
The American Cancer Society’s most recent estimates for kidney cancer in the United States for 2026 are:
- About 80,450 new cases of kidney cancer (50,770 in men and 29,680 in women) will be diagnosed.
- About 15,160 people (10,200 men and 4,960 women) will die from this disease.
These numbers include all types of kidney and renal pelvis cancers.
Most people with kidney cancer are older. The average age at diagnosis is 65, with most people diagnosed between 55 and 74. Kidney cancer is uncommon in people younger than age 45. It is about twice as common in men as in women. The disease is more common in African American, American Indian, and Alaska Native populations.
By making comprehensive kidney cancer support accessible online, Eisai and its partners hope to reduce the burden of initial diagnosis confusion. The platform reflects feedback from focus groups with people living with kidney cancer. Kompass therefore responds to real concerns rather than theoretical needs.
“Every person with kidney cancer faces unique challenges,” said Bryan Lewis, a kidney cancer survivor and CEO of KidneyCAN. He noted that tailored guidance and connection with others who understand the journey can help reduce feelings of isolation. It also empowers both patients and caregivers.
Advocacy groups involved in the effort emphasize the importance of community support in addition to clinical information. Peer-led networks, emotional support systems, and shared experiences are central to coping with the daily realities of living with kidney cancer, especially when treatments and prognosis vary widely.
The Kompass initiative arrives amid a broader push by patient organizations and healthcare stakeholders to enhance education and support for individuals facing serious illnesses. Digital resources such as Kompass play a growing role in bridging gaps in patient knowledge and access to reliable information. This is especially true in a landscape saturated with disparate online sources.
As kidney cancer research advances and new treatments emerge, having a centralized, credible educational hub helps patients stay informed about available options. Kompass’s launch reflects Eisai’s broader human health care mission, which extends beyond developing treatments to supporting patients and families throughout their disease journeys.
For those affected by kidney cancer and seeking guidance, Kompass offers a structured starting point. It brings clarity and resources together in one digital destination designed to inform, support, and empower.
Eisai’s platform represents a meaningful step toward improving access to kidney cancer information. It ensures that patients and caregivers can navigate the complexities of diagnosis and treatment with reliable tools and trusted support networks.
